vs

Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and Vertex, Inc. (VERX). Click either name above to swap in a different company.

Vertex, Inc. is the larger business by last-quarter revenue ($194.7M vs $182.4M, roughly 1.1× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs -3.6%, a 5.4% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs 9.1%). Over the past eight quarters, Climb Global Solutions, Inc.'s revenue compounded faster (40.7% CAGR vs 11.4%).

Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

CLMB vs VERX — Head-to-Head

Bigger by revenue
VERX
VERX
1.1× larger
VERX
$194.7M
$182.4M
CLMB
Growing faster (revenue YoY)
CLMB
CLMB
+23.0% gap
CLMB
32.1%
9.1%
VERX
Higher net margin
CLMB
CLMB
5.4% more per $
CLMB
1.8%
-3.6%
VERX
Faster 2-yr revenue CAGR
CLMB
CLMB
Annualised
CLMB
40.7%
11.4%
VERX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLMB
CLMB
VERX
VERX
Revenue
$182.4M
$194.7M
Net Profit
$3.3M
$-7.0M
Gross Margin
14.5%
64.8%
Operating Margin
2.1%
-1.3%
Net Margin
1.8%
-3.6%
Revenue YoY
32.1%
9.1%
Net Profit YoY
-9.5%
89.7%
EPS (diluted)
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLMB
CLMB
VERX
VERX
Q1 26
$182.4M
Q4 25
$193.8M
$194.7M
Q3 25
$161.3M
$192.1M
Q2 25
$159.3M
$184.6M
Q1 25
$138.0M
$177.1M
Q4 24
$161.8M
$178.5M
Q3 24
$119.3M
$170.4M
Q2 24
$92.1M
$161.1M
Net Profit
CLMB
CLMB
VERX
VERX
Q1 26
$3.3M
Q4 25
$7.0M
$-7.0M
Q3 25
$4.7M
$4.0M
Q2 25
$6.0M
$-961.0K
Q1 25
$3.7M
$11.1M
Q4 24
$7.0M
$-67.8M
Q3 24
$5.5M
$7.2M
Q2 24
$3.4M
$5.2M
Gross Margin
CLMB
CLMB
VERX
VERX
Q1 26
14.5%
Q4 25
15.4%
64.8%
Q3 25
15.9%
63.1%
Q2 25
16.5%
65.7%
Q1 25
16.9%
63.8%
Q4 24
19.3%
65.6%
Q3 24
20.3%
64.8%
Q2 24
20.2%
63.7%
Operating Margin
CLMB
CLMB
VERX
VERX
Q1 26
2.1%
Q4 25
4.9%
-1.3%
Q3 25
4.3%
2.2%
Q2 25
5.0%
-2.1%
Q1 25
3.5%
2.5%
Q4 24
7.2%
-7.3%
Q3 24
7.1%
2.9%
Q2 24
4.6%
4.7%
Net Margin
CLMB
CLMB
VERX
VERX
Q1 26
1.8%
Q4 25
3.6%
-3.6%
Q3 25
2.9%
2.1%
Q2 25
3.7%
-0.5%
Q1 25
2.7%
6.3%
Q4 24
4.3%
-38.0%
Q3 24
4.6%
4.2%
Q2 24
3.7%
3.2%
EPS (diluted)
CLMB
CLMB
VERX
VERX
Q1 26
$0.18
Q4 25
$1.51
Q3 25
$1.02
Q2 25
$1.30
Q1 25
$0.81
Q4 24
$1.52
Q3 24
$1.19
Q2 24
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLMB
CLMB
VERX
VERX
Cash + ST InvestmentsLiquidity on hand
$41.8M
$314.0M
Total DebtLower is stronger
$337.5M
Stockholders' EquityBook value
$118.4M
$258.9M
Total Assets
$458.8M
$1.3B
Debt / EquityLower = less leverage
1.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLMB
CLMB
VERX
VERX
Q1 26
$41.8M
Q4 25
$36.6M
$314.0M
Q3 25
$49.8M
$313.5M
Q2 25
$28.6M
$284.4M
Q1 25
$32.5M
$270.4M
Q4 24
$29.8M
$296.1M
Q3 24
$22.1M
$279.0M
Q2 24
$48.4M
$325.5M
Total Debt
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
$337.5M
Q3 25
$336.9M
Q2 25
$336.3M
Q1 25
$335.8M
Q4 24
$335.2M
Q3 24
$334.7M
Q2 24
$334.1M
Stockholders' Equity
CLMB
CLMB
VERX
VERX
Q1 26
$118.4M
Q4 25
$116.6M
$258.9M
Q3 25
$109.3M
$264.5M
Q2 25
$105.2M
$248.0M
Q1 25
$95.6M
$200.5M
Q4 24
$90.6M
$179.4M
Q3 24
$87.7M
$259.0M
Q2 24
$79.8M
$233.1M
Total Assets
CLMB
CLMB
VERX
VERX
Q1 26
$458.8M
Q4 25
$460.2M
$1.3B
Q3 25
$376.1M
$1.2B
Q2 25
$420.7M
$1.2B
Q1 25
$370.1M
$1.2B
Q4 24
$469.2M
$1.2B
Q3 24
$371.9M
$1.2B
Q2 24
$302.8M
$1.0B
Debt / Equity
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
1.30×
Q3 25
1.27×
Q2 25
1.36×
Q1 25
1.67×
Q4 24
1.87×
Q3 24
1.29×
Q2 24
1.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLMB
CLMB
VERX
VERX
Operating Cash FlowLast quarter
$42.3M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
$-11.9M
$42.3M
Q3 25
$22.2M
$62.5M
Q2 25
$-2.2M
$46.0M
Q1 25
$8.5M
$14.8M
Q4 24
$16.0M
$41.1M
Q3 24
$-3.6M
$41.4M
Q2 24
$7.3M
$57.7M
Free Cash Flow
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-24.3M
Q2 24
FCF Margin
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-14.2%
Q2 24
Capex Intensity
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
38.5%
Q2 24
Cash Conversion
CLMB
CLMB
VERX
VERX
Q1 26
Q4 25
-1.70×
Q3 25
4.73×
15.44×
Q2 25
-0.37×
Q1 25
2.30×
1.33×
Q4 24
2.29×
Q3 24
-0.66×
5.73×
Q2 24
2.13×
11.18×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLMB
CLMB

Segment breakdown not available.

VERX
VERX

Cloud Subscriptions$94.6M49%
Software Licenses$71.6M37%
Service Other$28.5M15%

Related Comparisons